Selene Cuenca Peris,Ana Flor Pérez,Cecilia López Valdivia
Selene Cuenca Peris
[Interstitial Lung Disease] [0.03%]
间质性肺病
Juan Margallo Iribarnegaray,María Churruca Arróspide,Cristina Matesanz López et al.
Juan Margallo Iribarnegaray et al.
Diffuse interstitial lung diseases (ILD) are a heterogeneous group of respiratory disorders that are usually classified together because they have similar clinical, radiological, physiological or pathological manifestations. In the last dec...
[Comparison of adherence as assessed by the Test of Adherence to Inhalers and Pharmacy Refill Records, in Asthma Patients. REFARMA study] [0.03%]
[评估哮喘患者吸入剂顺应性的测试：基于REFARMA研究的药房领药记录对比]
Miguel Santibáñez,Isabel Rodríguez,Juan Carlos López-Caro et al.
Miguel Santibáñez et al.
Introduction: Clinical guidelines recommend the combined use of "self-completed questionnaires such as the Test of Adherence to Inhalers (TAI)" and the pharmacy refill rate (PRR) to determine adherence, but evidence based...
Marina Blanco-Aparicio,Francisco José García-Río,Francisco Javier González-Barcala et al.
Marina Blanco-Aparicio et al.
Introduction: Asthma is a disease with high prevalence, which affects all age groups and generates high health and social care costs. Studies carried out in a number of populations show great variability in its prevalence...
Laura Costa,Sebastián Peñafiel,Dario Guamán et al.
Laura Costa et al.
Olaia Bronte-Moreno,Francisco-Javier González-Barcala,Xavier Muñoz-Gall et al.
Olaia Bronte-Moreno et al.
Asthma is the most common chronic respiratory disease and a major public health problem. Although the causal relationship between air pollution and asthma remains controversial, a large number of studies have provided increasingly consisten...
Agustín Muñoz-Cutillas,Sara Bellón-Alonso,Laura Oliva-García et al.
Agustín Muñoz-Cutillas et al.
Endobronchial Closure of Bronchopleural Fistulas Using Patent Foramen Ovale Occluder and Patent Ductus Arteriosus Occluder [0.03%]
房间隔缺损闭合器和动脉导管未闭闭合器封闭支气管胸膜瘘的临床研究
Inês Barreto,Francisca Godinho Oliveira,Paula Monteiro
Inês Barreto
Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma [0.03%]
-tezepelumab在重度哮喘治疗中的有效性和潜在定位分析-
Vicente Plaza,Conxa Cañete,Christian Domingo et al.
Vicente Plaza et al.
The excellent results for monoclonal antibodies in the treatment of severe uncontrolled asthma (SUCA) represent a milestone in current treatment of asthmatic disorders. Remaining, however, are several subsidiary areas for improvement in whi...
Franco Ernesto León-Jiménez,Sergio Rosas-Ruiz,Sofía Cavalcanti-Ramírez et al.
Franco Ernesto León-Jiménez et al.